Vishal Jain
Président chez Ansella Therapeutics, Inc.
Profil
Vishal Jain is currently the Vice Chairman at Infinion Biopharma Ltd., Chairman at Ansella Therapeutics, Inc., Director at Amphina Therapeutics Pvt Ltd., Director at Diabeato Healthcare Pvt Ltd., and Partner at Freyeur & Trogue, LLC.
He previously worked as the President at Enquyst Technologies Inc. Jain holds an MBA from Cornell University and an undergraduate degree from Veer Narmad South Gujarat University.
Postes actifs de Vishal Jain
| Sociétés | Poste | Début |
|---|---|---|
Infinion Biopharma Ltd.
 Infinion Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Infinion Biopharma Ltd. manufactures and sells pharmaceutical products. It is a research-driven life sciences company that combines biophysics and engineering with traditional pharmacology and biochemistry to produce high-value, innovative products across a range of therapeutic areas. Infinion has set up a global network of subsidiaries and portfolio companies focused on edge technologies across the health care spectrum including: Process Technology, Biotechnology, Formuation Technology. The company was founded on January 16, 2018 and is headquartered in Ahmedabad, India. | Directeur/Membre du Conseil | - |
| Amphina Therapeutics Pvt Ltd. | Directeur/Membre du Conseil | - |
| Diabeato Healthcare Pvt Ltd. | Directeur/Membre du Conseil | - |
Ansella Therapeutics, Inc.
 Ansella Therapeutics, Inc. BiotechnologyHealth Technology Ansella Therapeutics, Inc. develops therapeutic solutions for women's vaginal health. The company is based in Lowell, MA. The company was founded by Mark Goldstone. | Président | - |
Freyeur & Trogue, LLC
 Freyeur & Trogue, LLC Financial ConglomeratesFinance Freyeur & Trogue, LLC provides capital, advisory, and consulting services. The private company is based in New York, NY. | Corporate Officer/Principal | - |
Anciens postes connus de Vishal Jain
| Sociétés | Poste | Fin |
|---|---|---|
Enquyst Technologies Inc.
 Enquyst Technologies Inc. Medical SpecialtiesHealth Technology Enquyst Technologies Inc. is a company that is focused on developing next-generation biomanufacturing technology solutions to make life-changing and curative treatments more accessible and affordable for patients worldwide. The company is based in Lowell, MA and was founded by Jason Criscione. The company's patented technology is being applied to solve large unmet needs in the downstream purification of gene therapies, particularly AAV and lentiviral vector-based gene therapies. | President | - |
Formation de Vishal Jain
| Veer Narmad South Gujarat University | Undergraduate Degree |
| Cornell University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Infinion Biopharma Ltd.
Infinion Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Infinion Biopharma Ltd. manufactures and sells pharmaceutical products. It is a research-driven life sciences company that combines biophysics and engineering with traditional pharmacology and biochemistry to produce high-value, innovative products across a range of therapeutic areas. Infinion has set up a global network of subsidiaries and portfolio companies focused on edge technologies across the health care spectrum including: Process Technology, Biotechnology, Formuation Technology. The company was founded on January 16, 2018 and is headquartered in Ahmedabad, India. | Health Technology |
| Amphina Therapeutics Pvt Ltd. | |
| Diabeato Healthcare Pvt Ltd. | |
Ansella Therapeutics, Inc.
Ansella Therapeutics, Inc. BiotechnologyHealth Technology Ansella Therapeutics, Inc. develops therapeutic solutions for women's vaginal health. The company is based in Lowell, MA. The company was founded by Mark Goldstone. | Health Technology |
Enquyst Technologies Inc.
Enquyst Technologies Inc. Medical SpecialtiesHealth Technology Enquyst Technologies Inc. is a company that is focused on developing next-generation biomanufacturing technology solutions to make life-changing and curative treatments more accessible and affordable for patients worldwide. The company is based in Lowell, MA and was founded by Jason Criscione. The company's patented technology is being applied to solve large unmet needs in the downstream purification of gene therapies, particularly AAV and lentiviral vector-based gene therapies. | Health Technology |
Freyeur & Trogue, LLC
Freyeur & Trogue, LLC Financial ConglomeratesFinance Freyeur & Trogue, LLC provides capital, advisory, and consulting services. The private company is based in New York, NY. | Finance |
